Therapeutic selectivity and risk/benefit assessment of hypolipidemic drugs View on Open Library

Therapeutic selectivity and risk/benefit assessment of hypolipidemic drugs

by Giorgio Ricci

No reviews yet
First published: 1982 1 language ISBN: 0890046492
Subjects
Hyperlipidemia Antilipemic agents Drug therapy Side effects Chemotherapy Therapeutic use Testing Hyperlipemia Hypolipidemic Agents Hyperlipidemias

Reviews

Log in or sign up to write a review.

No reviews yet. Be the first!

More by Giorgio Ricci

Antibiotic Resistance in Nursing Homes

Antibiotic Resistance in Nursing Homes

Arteriopatie obliteranti degli arti inferiori

Arteriopatie obliteranti degli arti infe...

You Might Also Like

More in Hyperlipidemia
Ambulatory Care Clinical Skills Program

Ambulatory Care Clinical Skills Program

Mary Lynn McPherson
The gemfibrozil cost-benefit model

The gemfibrozil cost-benefit model

Syam Sarma
Practical lipid management

Practical lipid management

Peter P. Toth
Principles and treatment of lipoprotein disorders

Principles and treatment of lipoprotein ...

David H. Blankenhorn
Churchill's In Clinical Practice Series

Churchill's In Clinical Practice Series

David J. Galton
Drugs affecting lipid metabolism

Drugs affecting lipid metabolism

Rodolfo Paoletti